Anti–Vascular Endothelial Growth Factor Drugs for Retinal Conditions: Comparative Clinical Effectiveness and Guidelines

Details

Files

Project Status:

Completed

Project Line:

Reference List

Project Sub Line:

Summary of Abstracts

Project Number:

RB1415-000

Question

What is the comparative clinical effectiveness of anti-vascular endothelial growth factor drugs for the treatment of retinal conditions?
What are the evidence-based guidelines regarding the use of anti-vascular endothelial growth factor drugs for the treatment of retinal conditions?

Key Message

One overview of systematic reviews1,16 systematic reviews (with meta-analyses2-5,9-13,22,23 and network meta-analyses8,16,17,20,21), five meta-analyses6,7,15,18,19 and one network meta-anaylsis14 were identified regarding the comparative clinical effectiveness of anti-vascular endothelial growth factor drugs for the treatment of retinal conditions. In addition, one evidence-based guideline was identified regarding the use of anti-vascular endothelial growth factor drugs for the treatment of retinal conditions.

Files

Anti–Vascular Endothelial Growth Factor Drugs for Retinal Conditions: Comparative Clinical Effectiveness and Guidelines Rapid Response March 2, 2020 View PDF

Last Updated : April 16, 2020